Chronic Pain MedsCheck Trial
The Chronic Pain MedsCheck Trial is funded by the Australian Department of Health as part of the Sixth Community Pharmacy Agreement (6CPA) Pharmacy Trial Program (PTP).
The 6CPA PTP was established to trial new and expanded Community Pharmacy Programs that seek to improve clinical outcomes for consumers and by progressing the role of community pharmacies in the delivery of primary healthcare services.
The Chronic Pain MedsCheck Trial objective is to evaluate the efficacy of the Chronic Pain MedsCheck service in:
- preventing incorrect use and/or overuse of pain medication,
- increasing patients’ pain medication health literacy,
- improving their ability to self-manage their chronic pain, and;
- improving their overall quality of life
The Trial Intervention
The Chronic Pain MedsCheck Trial is a Pharmacy Trial Program (PTP) that will trial the delivery of a specialised Chronic Pain MedsCheck within community pharmacy.
The trial intervention from community pharmacy will include:
- supported self -management of patients taking medication who are dealing with chronic pain for more than three months through pharmacist advice;
- pharmacy-based evaluation of patient’s medicine, and;
- provision of an action plan
- action plans will incorporate education, self-management and referral to other health professionals where additional support is required.
- three month follow up after the initial service
The Chronic Pain MedsCheck trial includes two randomly selected intervention groups, Group A and Group B:
Group A: Involves an initial in-pharmacy face-to-face consultation between the pharmacist and the consumer and a three month follow up consultation.
Group B: Involves an initial in-pharmacy face-to-face consultation between the pharmacist and the consumer; a six week midpoint follow up consultation by telephone, and a three month follow up consultation.
From each group will also be randomly selected a number of evaluation pharmacies, to provide additional information on the intervention. These pharmacies will provided appropriate remuneration for the additional request of their time, please see the Pharmacy/Pharmacist Information Statement for more details.
The Chronic Pain MedsCheck Trial service will include the provision of information about accessing additional support, or where appropriate a referral to the patients’ GP or allied health professional.
Community pharmacies delivering Chronic Pain MedsChecks will be encouraged to build relationships with other health professionals providing support for patients with chronic pain.
For more detail about the service, please read the Pharmacy/Pharmacist Information Statement.
If a pharmacy agrees to participate, all pharmacists participating in the trial are obliged to complete free CPD accredited online training modules. The Chronic Pain MedsCheck Trial training program which will explain:
- the trial design,
- requirements of pharmacies in each group,
- types of patients that are suitable for invitation to the trial,
- suggested process for identifying patients that meet the trial criteria,
- the intervention process including data collection requirements.
In addition, pharmacies that are randomised to be an evaluation trial site will be involved in an additional free online CPD training accredited training session on the evaluation trial site specific requirements.
Once pharmacists have completed the training, the pharmacy will be asked to recruit around 40 patients until 1 June 2019 that meet the trial criteria.
The trial target population includes patients living with ongoing chronic pain for three or more months who may be experiencing self-management problems or pain medication dependency.
The requirements for participation are listed under the Pharmacy/Pharmacist Information Statement, and all pharmacies must complete the Chronic Pain MedsCheck compulsory online training modules prior to conducting services.
Community pharmacies participating in the Chronic Pain MedsCheck Trial will be required to collect and provide a minimum set of data (where patient consent has been obtained) to the 6CPA Administrator on patients and their experience of the service. They will be reimbursed as part of the service.
Further information including pharmacy trial payments can be found in the Pharmacy/Pharmacist Information Statement.
Registrations for the trial are now closed. Offers of participation will be made to pharmacies over the next few weeks.
You can call the 6CPA Helpline on 1300 555 262 or email firstname.lastname@example.org for any further queries.